NCT06824532 Veteran's Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-Life
| NCT ID | NCT06824532 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Albany Research Institute, Inc. |
| Condition | Depression |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-11-08 |
| Primary Completion | 2025-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2024-11-08 with a primary completion date of 2025-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this exploratory, mixed-method design study is to gather qualitative and quantitative data obtained through interviews and questionnaires with veterans who are currently enrolled at the VA for healthcare. The main question this study aims to answer is: How do veterans aged 65+ who are enrolled for care at the VA understand ketamine assisted psychotherapy for depression and for end-of-life distress? Using a story-completion approach, participants will be provided with a brief story starter involving a fictitious character and scenario and asking them to complete the story. Few contextual details will be offered about the character. In responding to ambiguous cues, participants are thought to project their conscious and subconscious perceptions about the phenomenon in question onto the story, a useful method for exploring stigmatized topics. The purpose of this exercise is to ascertain the participants attitudes and perceptions regarding ketamine assisted psychotherapy.
Eligibility Criteria
Inclusion Criteria: * Veterans enrolled in VA care. * Age 65 or older. * Fluent in written and spoken English. Exclusion Criteria: * Cognitively impaired to the extent that patient cannot comprehend the survey.
Contact & Investigator
Caitlin Holley, Ph.D.
PRINCIPAL INVESTIGATOR
Albany Research Institute, Inc.
Frequently Asked Questions
Who can join the NCT06824532 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06824532 currently recruiting?
Yes, NCT06824532 is actively recruiting participants. Contact the research team at caitlin.holley@va.gov for enrollment information.
Where is the NCT06824532 trial being conducted?
This trial is being conducted at Albany, United States.
Who is sponsoring the NCT06824532 clinical trial?
NCT06824532 is sponsored by Albany Research Institute, Inc.. The principal investigator is Caitlin Holley, Ph.D. at Albany Research Institute, Inc.. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.